456 related articles for article (PubMed ID: 15581975)
21. Prognostic factors and outcome in women with uterine sarcoma.
Denschlag D; Masoud I; Stanimir G; Gilbert L
Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
[TBL] [Abstract][Full Text] [Related]
22. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
Lim P; Aquino-Parsons CF; Wong F; Dupuis B; Phillips D; Zhou C; Gilks CB
Gynecol Oncol; 1999 May; 73(2):191-5. PubMed ID: 10329033
[TBL] [Abstract][Full Text] [Related]
23. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
[TBL] [Abstract][Full Text] [Related]
24. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
25. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
26. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
27. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
[TBL] [Abstract][Full Text] [Related]
28. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
[TBL] [Abstract][Full Text] [Related]
29. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
Leiser AL; Hamid AM; Blanchard R
Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205
[TBL] [Abstract][Full Text] [Related]
30. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.
Bautista N; Su W; O'Connell TX
Am Surg; 2000 Sep; 66(9):832-6. PubMed ID: 10993610
[TBL] [Abstract][Full Text] [Related]
31. Endometrial stromal neoplasms of the uterus. A clinicopathologic study.
Sieiński W
Patol Pol; 1992; 43(1):30-4. PubMed ID: 1296171
[TBL] [Abstract][Full Text] [Related]
32. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer.
Goudge C; Bernhard S; Cloven NG; Morris P
Gynecol Oncol; 2004 May; 93(2):536-9. PubMed ID: 15099975
[TBL] [Abstract][Full Text] [Related]
33. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
34. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors, treatment and outcome in a Turkish population with endometrial stromal sarcoma.
Donertas A; Nayki U; Nayki C; Ulug P; Gultekin E; Yildirim Y
Asian Pac J Cancer Prev; 2015; 16(3):881-7. PubMed ID: 25735377
[TBL] [Abstract][Full Text] [Related]
36. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.
Bartosch C; Exposito MI; Lopes JM
Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859
[TBL] [Abstract][Full Text] [Related]
37. Uterine Endometrial Stromal Tumors With Pure Low-Grade Morphology Harboring YWHAE::NUTM2 Fusions: Report of a Case Series Emphasizing Potential for High-Grade Transformation and Aggressive Behavior.
Devins KM; Attygalle AD; Croce S; Vroobel K; Oliva E; McCluggage WG
Am J Surg Pathol; 2023 Jun; 47(6):717-724. PubMed ID: 37032555
[TBL] [Abstract][Full Text] [Related]
38. Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment.
Beck TL; Singhal PK; Ehrenberg HM; Rose PG; Lele SB; Krivak TC; McBee WC
Gynecol Oncol; 2012 Apr; 125(1):141-4. PubMed ID: 22119993
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
[TBL] [Abstract][Full Text] [Related]
40. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Singer S
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
